Form 4: Firefly Neuroscience Director Vnook Receives Deferred Stock Units

Stella Vnook, a director at Firefly Neuroscience, was granted 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.

Summary

• On March 10, 2025, Stella Vnook, a director of Firefly Neuroscience, Inc., received 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.
• 8,333 DSUs vested immediately upon grant.
• An additional 4,167 DSUs will vest on June 10, 2025, and another 4,167 DSUs will vest on September 10, 2025.
• Each DSU represents a contingent right to receive one share of Firefly Neuroscience common stock.

Sentiment

Score: 7

Explanation: The document indicates a standard compensation practice, suggesting stability and alignment of interests. The vesting schedule is a positive sign.

Positives

• The grant of DSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company's success.

Future Outlook

The vesting schedule of the DSUs suggests an expectation of continued service and contribution from the director over the coming months.

Industry Context

Granting stock-based compensation, such as DSUs, is a common practice in the neuroscience and biotechnology industries to attract, retain, and incentivize key personnel.

Stakeholder Impact

• Shareholders may view the DSU grant as a positive incentive for the director to contribute to the company's long-term success.

Key Dates